Andrew Muir
Geen lopende functies
Profiel
Andrew R.
Muir served as Chairman at Select Therapeutics, Inc. He was also a Director at Satcon Technology Corp.
from 2004 to 2007.
Additionally, he served as a Non-Executive Director at Christie Group Plc.
Dr. Muir holds a doctorate from the University of Oxford and an MBA from Pace University.
Eerdere bekende functies van Andrew Muir
Bedrijven | Functie | Einde |
---|---|---|
SATCON TECHNOLOGY CORPORATION | Directeur/Bestuurslid | 20-12-2007 |
CHRISTIE GROUP PLC | Directeur/Bestuurslid | 27-06-2005 |
Select Therapeutics, Inc.
Select Therapeutics, Inc. Pharmaceuticals: GenericHealth Technology Select Therapeutics, Inc. operates as a development stage biopharmaceutical company. It is focused on the development of cell based therapeutics production. The company was founded by Clifford A. Lingwood in January 1997 and is headquartered in Brookline, MA. | Voorzitter | - |
Opleiding van Andrew Muir
Pace University | Masters Business Admin |
University of Oxford | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
CHRISTIE GROUP PLC | Commercial Services |
Bedrijven in privébezit | 2 |
---|---|
Satcon Technology Corp.
Satcon Technology Corp. SemiconductorsElectronic Technology Satcon Technology Corp. operates as a energy and power company. It provides system design services for utility-scale renewable energy plants. The firm designs and delivers advanced power conversion solutions that enable producers of renewable energy to convert clean energy into grid-connected and reliable electrical power. The company was founded by David B. Eisenhaure in February 1985 and is headquartered in Boston, MA. | Electronic Technology |
Select Therapeutics, Inc.
Select Therapeutics, Inc. Pharmaceuticals: GenericHealth Technology Select Therapeutics, Inc. operates as a development stage biopharmaceutical company. It is focused on the development of cell based therapeutics production. The company was founded by Clifford A. Lingwood in January 1997 and is headquartered in Brookline, MA. | Health Technology |